Who owns Indaptus Therapeutics Inc?
- Ticker: INDP
- CUSIP Number: 45339j204
Tip: Access positions for across all investors
Analyze quarterly positions in Indaptus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Indaptus Therapeutics stock
Who bought or sold Indaptus Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 39k | $71k | 100% | Mar 2026 |
|
| Geode Capital Management | 27k | $49k | 100% | Mar 2026 |
|
| Morgan Stanley | 2.7k | $4.9k | 100% | Mar 2026 |
|
| Tower Research Capital | 1.9k | $3.4k | -40% | Mar 2026 |
|
| SBI Securities | 17.00 | $30.999500 | 0% | Mar 2026 |
|
| CWM | 2.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Indaptus Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2025 | 29k | $84k |